Related Experiment Video
Updated: Sep 7, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression
Abigail Dove1, Anna Marseglia2, Ying Shang3
1Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Multiple cardiometabolic diseases (CMDs) significantly accelerate cognitive decline and increase the risk of cognitive impairment, no dementia (CIND), and dementia in older adults.
Area of Science:
- Neurology
- Gerontology
- Cardiology
Background:
- Cardiometabolic diseases (CMDs) are individually linked to cognitive decline.
- The combined impact of multiple CMDs on cognitive health remains under-investigated.
Purpose of the Study:
- To investigate the cumulative effect of cardiometabolic diseases on cognitive function in older adults.
- To determine if cardiometabolic multimorbidity accelerates cognitive decline and the onset of dementia.
Main Methods:
- Longitudinal study of 2577 dementia-free adults aged 60+ over 12 years.
- Assessed cardiometabolic diseases (type 2 diabetes, heart disease, stroke) and cardiometabolic multimorbidity (≥2 CMDs) at baseline.
- Utilized linear mixed-effects models, Cox regression, and Laplace regression to analyze cognitive changes and incident cognitive impairment, no dementia (CIND) and dementia.
Main Results:
- Cardiometabolic multimorbidity was significantly associated with accelerated cognitive decline.
- Increased risk of CIND (HR 1.73) and dementia (HR 1.86) observed with CMD multimorbidity.
- CMD multimorbidity advanced the onset of CIND by 2.3 years and dementia by 1.8 years.
Conclusions:
- Cardiometabolic multimorbidity accelerates cognitive decline and elevates the risk of cognitive impairment and dementia.
- Targeting co-morbid CMDs may be crucial for interventions aimed at preserving cognitive health in aging populations.
Related Concept Videos
Coronary Artery Disease I: Introduction
Dementia
The progression of dementia is generally gradual....
Cardiomyopathy II: Dilated Cardiomyopathy
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cardiomyopathy III: Hypertrophic Cardiomyopathy

